Annual EBITDA
-$22.13 M
+$17.40 M+44.01%
31 December 2023
Summary:
180 Life Sciences annual earnings before interest, taxes, depreciation & amortization is currently -$22.13 million, with the most recent change of +$17.40 million (+44.01%) on 31 December 2023. During the last 3 years, it has fallen by -$2.08 million (-10.38%). ATNF annual EBITDA is now -128.37% below its all-time high of -$9.69 million, reached on 31 December 2020.ATNF EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$809.20 K
-$856.30 K-1818.05%
30 September 2024
Summary:
180 Life Sciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$809.20 thousand, with the most recent change of -$856.30 thousand (-1818.05%) on 30 September 2024. Over the past year, it has increased by +$389.60 thousand (+32.50%). ATNF quarterly EBITDA is now -104.41% below its all-time high of $18.35 million, reached on 30 September 2021.ATNF Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$2.99 M
+$11.76 M+79.72%
30 September 2024
Summary:
180 Life Sciences TTM earnings before interest, taxes, depreciation & amortization is currently -$2.99 million, with the most recent change of +$11.76 million (+79.72%) on 30 September 2024. Over the past year, it has increased by +$19.14 million (+86.49%). ATNF TTM EBITDA is now -112.47% below its all-time high of $23.99 million, reached on 30 June 2022.ATNF TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATNF EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +32.5% | +86.5% |
| 3 y3 years | -10.4% | -176.4% | +85.1% |
| 5 y5 years | +12.0% | +96.8% | +88.3% |
ATNF EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -10.4% | +44.0% | -127.1% | +96.4% | -112.5% | +94.3% |
| 5 y | 5 years | -128.4% | +44.0% | -104.4% | +96.8% | -112.5% | +94.3% |
| alltime | all time | -128.4% | +44.0% | -104.4% | +96.8% | -112.5% | +94.3% |
180 Life Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$809.20 K(-1818.0%) | -$2.99 M(-79.7%) |
| June 2024 | - | $47.10 K(-104.6%) | -$14.75 M(-20.0%) |
| Mar 2024 | - | -$1.03 M(-14.1%) | -$18.43 M(-16.7%) |
| Dec 2023 | -$22.13 M(-44.0%) | -$1.20 M(-90.5%) | -$22.13 M(-49.2%) |
| Sept 2023 | - | -$12.57 M(+245.2%) | -$43.58 M(-17.0%) |
| June 2023 | - | -$3.64 M(-23.0%) | -$52.48 M(+14.4%) |
| Mar 2023 | - | -$4.73 M(-79.1%) | -$45.86 M(+16.0%) |
| Dec 2022 | -$39.53 M(+97.1%) | -$22.64 M(+5.5%) | -$39.53 M(+149.7%) |
| Sept 2022 | - | -$21.47 M(-819.2%) | -$15.83 M(-166.0%) |
| June 2022 | - | $2.99 M(+86.8%) | $23.99 M(-1097.1%) |
| Mar 2022 | - | $1.60 M(+50.8%) | -$2.41 M(-88.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$20.05 M(+106.9%) | $1.06 M(-94.2%) | -$20.05 M(-29.4%) |
| Sept 2021 | - | $18.35 M(-178.4%) | -$28.41 M(-40.1%) |
| June 2021 | - | -$23.41 M(+45.9%) | -$47.45 M(+101.4%) |
| Mar 2021 | - | -$16.05 M(+119.8%) | -$23.56 M(+143.1%) |
| Dec 2020 | -$9.69 M(-61.5%) | -$7.30 M(+947.0%) | -$9.69 M(-65.4%) |
| Sept 2020 | - | -$697.30 K(-243.2%) | -$28.03 M(+2.7%) |
| June 2020 | - | $486.80 K(-122.3%) | -$27.30 M(-1.5%) |
| Mar 2020 | - | -$2.18 M(-91.5%) | -$27.73 M(+8.5%) |
| Dec 2019 | -$25.15 M | -$25.64 M(<-9900.0%) | -$25.55 M(<-9900.0%) |
| Sept 2019 | - | $29.60 K(-50.3%) | $89.20 K(+49.7%) |
| June 2019 | - | $59.60 K | $59.60 K |
FAQ
- What is 180 Life Sciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for 180 Life Sciences?
- What is 180 Life Sciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for 180 Life Sciences?
- What is 180 Life Sciences quarterly EBITDA year-on-year change?
- What is 180 Life Sciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for 180 Life Sciences?
- What is 180 Life Sciences TTM EBITDA year-on-year change?
What is 180 Life Sciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ATNF is -$22.13 M
What is the all time high annual EBITDA for 180 Life Sciences?
180 Life Sciences all-time high annual earnings before interest, taxes, depreciation & amortization is -$9.69 M
What is 180 Life Sciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ATNF is -$809.20 K
What is the all time high quarterly EBITDA for 180 Life Sciences?
180 Life Sciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $18.35 M
What is 180 Life Sciences quarterly EBITDA year-on-year change?
Over the past year, ATNF quarterly earnings before interest, taxes, depreciation & amortization has changed by +$389.60 K (+32.50%)
What is 180 Life Sciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ATNF is -$2.99 M
What is the all time high TTM EBITDA for 180 Life Sciences?
180 Life Sciences all-time high TTM earnings before interest, taxes, depreciation & amortization is $23.99 M
What is 180 Life Sciences TTM EBITDA year-on-year change?
Over the past year, ATNF TTM earnings before interest, taxes, depreciation & amortization has changed by +$19.14 M (+86.49%)